US Bancorp DE Sells 11,457 Shares of Bath & Body Works, Inc. (NYSE:BBWI)

US Bancorp DE lessened its position in Bath & Body Works, Inc. (NYSE:BBWIFree Report) by 68.8% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 5,197 shares of the company’s stock after selling 11,457 shares during the period. US Bancorp DE’s holdings in Bath & Body Works were worth $166,000 as of its most recent filing with the SEC.

Several other large investors have also recently bought and sold shares of the company. First Community Trust NA acquired a new position in shares of Bath & Body Works in the 2nd quarter valued at $30,000. Livforsakringsbolaget Skandia Omsesidigt increased its holdings in shares of Bath & Body Works by 300.0% in the third quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,200 shares of the company’s stock worth $38,000 after acquiring an additional 900 shares in the last quarter. EntryPoint Capital LLC increased its holdings in shares of Bath & Body Works by 224.0% in the first quarter. EntryPoint Capital LLC now owns 1,471 shares of the company’s stock worth $74,000 after acquiring an additional 1,017 shares in the last quarter. GAMMA Investing LLC raised its position in shares of Bath & Body Works by 65.4% during the second quarter. GAMMA Investing LLC now owns 1,846 shares of the company’s stock worth $72,000 after purchasing an additional 730 shares during the period. Finally, Blue Trust Inc. lifted its holdings in shares of Bath & Body Works by 23.4% during the 2nd quarter. Blue Trust Inc. now owns 2,767 shares of the company’s stock valued at $108,000 after purchasing an additional 524 shares in the last quarter. Institutional investors own 95.14% of the company’s stock.

Insider Activity

In related news, CEO Gina Boswell acquired 6,000 shares of the company’s stock in a transaction dated Wednesday, October 9th. The shares were bought at an average cost of $29.64 per share, with a total value of $177,840.00. Following the completion of the transaction, the chief executive officer now directly owns 242,987 shares of the company’s stock, valued at $7,202,134.68. This trade represents a 2.53 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through the SEC website. Insiders own 0.27% of the company’s stock.

Analyst Ratings Changes

BBWI has been the subject of a number of research reports. Barclays cut Bath & Body Works from an “equal weight” rating to an “underweight” rating and lowered their target price for the stock from $31.00 to $28.00 in a research note on Friday, November 8th. Deutsche Bank Aktiengesellschaft dropped their price objective on shares of Bath & Body Works from $57.00 to $54.00 and set a “buy” rating on the stock in a report on Monday, August 26th. Citigroup reduced their target price on shares of Bath & Body Works from $48.00 to $35.00 and set a “neutral” rating for the company in a research note on Tuesday, August 20th. Raymond James dropped their price target on Bath & Body Works from $51.00 to $42.00 and set an “outperform” rating on the stock in a research note on Thursday, August 29th. Finally, BMO Capital Markets reaffirmed an “outperform” rating and set a $50.00 price objective (down from $52.00) on shares of Bath & Body Works in a research report on Thursday, August 29th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and nine have assigned a buy rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $42.44.

Check Out Our Latest Research Report on BBWI

Bath & Body Works Trading Down 0.9 %

NYSE:BBWI opened at $31.34 on Friday. The stock has a market capitalization of $6.87 billion, a PE ratio of 7.59, a P/E/G ratio of 1.00 and a beta of 1.79. Bath & Body Works, Inc. has a 1-year low of $26.20 and a 1-year high of $52.99. The firm has a fifty day simple moving average of $30.12 and a 200 day simple moving average of $36.60.

Bath & Body Works (NYSE:BBWIGet Free Report) last announced its quarterly earnings data on Wednesday, August 28th. The company reported $0.37 EPS for the quarter, beating analysts’ consensus estimates of $0.35 by $0.02. The company had revenue of $1.53 billion during the quarter, compared to the consensus estimate of $1.54 billion. Bath & Body Works had a net margin of 12.69% and a negative return on equity of 41.94%. On average, equities analysts predict that Bath & Body Works, Inc. will post 3.18 earnings per share for the current fiscal year.

Bath & Body Works Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 6th. Shareholders of record on Friday, November 22nd will be paid a $0.20 dividend. The ex-dividend date of this dividend is Friday, November 22nd. This represents a $0.80 annualized dividend and a yield of 2.55%. Bath & Body Works’s dividend payout ratio is 19.37%.

Bath & Body Works Profile

(Free Report)

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.

Further Reading

Institutional Ownership by Quarter for Bath & Body Works (NYSE:BBWI)

Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.